Literature DB >> 3552990

Cloning and expression in Escherichia coli of the Ibc protein genes of group B streptococci: binding of human immunoglobulin A to the beta antigen.

P H Cleat, K N Timmis.   

Abstract

Total-cell DNA isolated from a highly virulent serotype Ic strain of a group B streptococcus was used to construct a gene bank with bacteriophage lambda L47.1 in Escherichia coli K-12. Recombinant phage plaques in the bank were immunoblotted by using anti-alpha- and anti-beta-specific antibodies directed towards the Ibc proteins purified from the streptococcal cell surface, and hybrid phages expressing the alpha protein (lambda alpha +) and the beta protein (lambda beta +) were identified. DNA inserts in these phages were subcloned into E. coli high-copy-number plasmid vectors to produce stable alpha + (pPHC10) and beta + (pPHC8 and pPHC33) recombinant plasmids, and restriction maps of the cloned streptococcal sequences were constructed. Antibodies against the two Streptococcus-derived proteins reacted with high-molecular-weight polypeptides made in E. coli cells carrying the corresponding hybrid plasmids and with several degradation peptides from them. A 190-kilodalton alpha protein, previously undetected, was identified; this species may be the native alpha protein or a precursor of it. In addition, mutagenesis of the cloned sequences was carried out by using the omega fragment to determine the direction of transcription. In E. coli, the beta protein, but not the alpha protein, bound human immunoglobulin A (IgA) in Western blots, and neither protein bound IgG or IgM.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552990      PMCID: PMC260483          DOI: 10.1128/iai.55.5.1151-1155.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  PREPARATION OF TRANSFORMING DEOXYRIBONUCLEIC ACID BY PHENOL TREATMENT.

Authors:  H SAITO; K I MIURA
Journal:  Biochim Biophys Acta       Date:  1963-08-20

2.  Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody.

Authors:  M V Valtonen; D L Kasper; N J Levy
Journal:  Microb Pathog       Date:  1986-04       Impact factor: 3.738

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Electron microscopic evidence of antibody entry into neutrophils after phagocytosis of highly virulent group B streptococci.

Authors:  P H Cleat; C Wells; C R Coid
Journal:  J Gen Microbiol       Date:  1984-11

5.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  Mouse-protective antibodies against the Ibc proteins of group B streptococci.

Authors:  L Bevanger; A I Naess
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1985-04

7.  Cloning of the gene encoding the hydrogenase from Desulfovibrio vulgaris (Hildenborough) and determination of the NH2-terminal sequence.

Authors:  G Voordouw; J E Walker; S Brenner
Journal:  Eur J Biochem       Date:  1985-05-02

8.  Cloning and genetic analysis of serotype 5 M protein determinant of group A streptococci: evidence for multiple copies of the M5 determinant in the Streptococcus pyogenes genome.

Authors:  M A Kehoe; T P Poirier; E H Beachey; K N Timmis
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

9.  Identification of protein antigens of group B streptococci, with special reference to the Ibc antigens.

Authors:  G J Russell-Jones; E C Gotschlich
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

10.  A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen.

Authors:  G J Russell-Jones; E C Gotschlich; M S Blake
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  9 in total

1.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen.

Authors:  L J Brady; M D Boyle
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

3.  Streptococcus agalactiae CAMP factor/protein B does not bind to human IgG.

Authors:  Waseem El-Huneidi; Ryan Mui; Tian Hua Zhang; Michael Palmer
Journal:  Med Microbiol Immunol       Date:  2006-11-04       Impact factor: 3.402

4.  Colloidal gold immunolabeling of immunoglobulin-binding sites and beta antigen in group B streptococci.

Authors:  S E Coleman; L J Brady; M D Boyle
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

5.  Nonimmune binding of human immunoglobulin A to type II group B streptococci.

Authors:  B F Anthony; N F Concepcion; S M Puentes; N R Payne
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci.

Authors:  P G Jerlström; S R Talay; P Valentin-Weigand; K N Timmis; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

7.  Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.

Authors:  J L Michel; L C Madoff; D E Kling; D L Kasper; F M Ausubel
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

8.  A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci.

Authors:  L C Madoff; J L Michel; D L Kasper
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci.

Authors:  J L Michel; L C Madoff; K Olson; D E Kling; D L Kasper; F M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.